Evaluating ApoE genotype, particularly distinguishing ApoE ε3 from ApoE ε4 carriers, could therefore add value to traditional thrombophilia screening, especially in complex or unexplained thrombotic cases. The gene discussed is APOE; the disease is thrombophilia.